Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 2,839 $ 2,772
Restricted cash 600 600
Accounts receivable, net of allowance for doubtful accounts of $135 and $275, respectively 7,851 8,028
Other current assets 2,975 2,722
Total current assets 14,265 14,122
Property and equipment, net 6,900 7,349
Other intangible assets, net 10,238 11,351
Goodwill 8,433 8,433
Operating lease right of use assets 3,980 4,384
Other long-term assets 42 42
Total assets 43,858 45,681
Current liabilities:    
Accounts payable 3,008 4,511
Accrued salary and bonus 2,173 3,161
Loan payable - related parties 5,092
Other accrued expenses 9,422 9,795
Current liabilities from discontinued operations 766 766
Total current liabilities 20,461 18,233
Contingent consideration 1,739 1,818
Operating lease liabilities, net of current portion 3,326 3,540
Other long-term liabilities 4,692 4,637
Total liabilities 30,218 28,228
Commitments and contingencies (Note 12)
Stockholders' deficit:    
Common stock, $.01 par value; 100,000,000 shares authorized; 4,132,507 and 4,075,257 shares issued, respectively; 4,112,843 and 4,055,593 shares outstanding, respectively 402 402
Additional paid-in capital 184,798 184,404
Accumulated deficit (216,323) (212,116)
Treasury stock, at cost (19,664 and 19,664 shares, respectively) (1,773) (1,773)
Total stockholders' deficit (32,896) (29,083)
Total liabilities and stockholders' deficit (2,678) (855)
Total liabilities, preferred stock and stockholders' deficit 43,858 45,681
Series B [Member]    
Current liabilities:    
Preferred stock, $.01 par value; 5,000,000 shares authorized, 47,000 Series B issued and outstanding $ 46,536 $ 46,536